August 2024, Vol 5, No. 8

This Viewpoint discusses the emergence of telemedicine as a potential treatment option for alcohol use disorder and highlights the advantages, disadvantages, and barriers of this care model.

This economic evaluation assesses drug price changes after patent expirations in 8 high-income countries and what the implications are for cost-effectiveness analyses.

This survey study compares post–COVID-19 pandemic operational characteristics and capabilities of federally qualified health centers with non–federally qualified health centers.

This JAMA Forum discusses the cost of newly approved weight loss medications in the US compared with other countries and provides arguments for why these medications should be more available for individuals in the US and covered by more insurers.

This Viewpoint details the findings of a report from the National Academies of Sciences, Engineering, and Medicine on family caregiving among those in science, technology, engineering, mathematics, and medicine.

This cluster randomized clinical trial aims to determine if tailored practice facilitation improved rates of recommended screening and management of unhealthy alcohol use compared to usual care.

This retrospective encounter-based analysis evaluates the impact of step therapy on macular degeneration drug prescribing patterns among 3 large Medicare Advantage insurers.

This JAMA Forum discusses the current data collection mechanisms used for Medicare and proposes ways to improve nationwide data collection efforts for Medicaid.

This Viewpoint describes the need for more health care organizations to include disability accessibility information on their websites and to improve physical access for patients with disabilities.

This difference-in-differences study explores the association of vertical relationships between primary care physicians and large health systems regarding quality of care.

This cross-sectional study examines trends in US prescription fills for semaglutide products by payment method between January 2021 and December 2023.

This Special Comunication proposes national goals based on a community-led consensus model to propose policy and clinical changes to improve outcomes that matter to people with intellectual and/or developmental disabilities.

This JAMA Forum discusses patient- and population-level nonadherence to medical advice and elaborates on 4 main categories of reasons that underpin nonadherence.